Anika Therapeutics, Inc.

ANIK · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$56-$83-$15$4
Dep. & Amort.$8$14$14$14
Deferred Tax$0-$6-$5-$2
Stock-Based Comp.$13$15$14$11
Change in WC-$13-$12-$12-$15
Other Non-Cash$53$70$8-$5
Operating Cash Flow$5-$2$4$8
Investing Activities
PP&E Inv.-$8-$5-$7-$5
Net Acquisitions$0$0$0-$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$3
Other Inv. Act.-$1$0$0$0
Investing Cash Flow-$8-$5-$7-$3
Financing Activities
Debt Repay.$0$0-$0-$0
Stock Issued$0$0$0$0
Stock Repurch.-$11-$5$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$2-$1-$5-$7
Financing Cash Flow-$13-$6-$5-$7
Forex Effect-$0$0-$0$0
Net Chg. in Cash-$16-$13-$8-$1
Supplemental Information
Beg. Cash$73$86$94$96
End Cash$57$73$86$94
Free Cash Flow-$2-$7-$3$3